On Air Now

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 100.7 FM Terre Haute, IN

Weather

Current Conditions(Terre Haute,IN 47807)

More Weather »
52° Feels Like: 52°
Wind: S 0 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Mostly Cloudy 80°

Tonight

Isolated Thunderstorms 67°

Tomorrow

Isolated Thunderstorms 89°

Alerts

GlaxoSmithKline lung drug Anoro approved in Europe

LONDON (Reuters) - GlaxoSmithKline said on Thursday its new inhaled lung drug, Anoro, had been approved in Europe as a treatment for chronic lung disease, boosting its respiratory franchise.

A final green light had been expected for the product, which was developed with Theravance, following a recommendation from European experts in February.

Respiratory drugs are a major business for GSK. Advair or Seretide, its market-leading lung drug, makes up a fifth of its sales, but it is already facing competition from generic versions in Europe.

Industry analysts expect Anoro to generate worldwide annual sales of about $2.65 billion by 2019, according to Thomson Reuters data.

(Reporting by Ben Hirschler; editing by Jane Baird)

Comments